Ocular Therapeutix Inc (OCUL) 13F Filings: Institutional Buyers & Sellers (Q2 2026)

OCUL ranks #2367 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

OCUL is a top-conviction position for Summer Road LLC — at 74.5% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in OCUL belongs to FMR LLC, but the position matters far more to Summer Road LLC, who has 74.5% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Farther Finance Advisors, LLC has added to its OCUL position for two straight quarters, increasing it by $5.0K to reach $15.4K today.

Vontobel Holding Ltd. has trimmed its OCUL position for two straight quarters, cutting it by $1.1M while still holding $81.5K.

OCUL is up 2.5% today, and institutions have been net buyers of $92.6M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

OCUL reported a net loss of $301.4M over the trailing twelve months.

• Not yet profitable — net loss of $301.4M over the trailing twelve months
• Revenue declined 8.1% year over year
• Net income declined year over year, from -$216.7M to -$301.4M
• Operating cash flow was negative, using $204.9M in cash
• Current ratio of 15.39x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.23x equity — within a conventional range